Industry firm on joint risk upgrade, but EC yet to soften
This article was originally published in Clinica
Executive Summary
As officials within the European Commission's medical devices unit still wait to hear from Enterprise and Information Society Commissioner Erkki Liikanen whether they should press ahead with the directive on the reclassification of joint implants, there are no signs yet that the Commissioner is likely to support industry's position for a fundamental change in the text.